Two LMU Researchers Awarded the Heinz Maier-Leibnitz Prize

Enlarge

The Heinz Maier-Leibnitz Prize is regarded as the most prestigious award for researchers in the early stages of their careers in Germany. It is awarded by the German Research Foundation (DFG) and is endowed with 200,000 Euros for each recipient.

Professor Benjamin Loy, a scholar of Romance studies, has expanded the boundaries of traditional national literatures and focuses his research on what is often referred to as the “new” world literature from Latin America. His work demonstrates, among other things, how literary texts shape conceptions of society and how writings from the Global South challenge established Western notions of literature and epistemological categories. Drawing on authors such as Roberto Bolaño, Loy examines transcultural narrative forms that aesthetically engage with experiences of colonialism, violence, and alternative ways of understanding the world.

“Literature remains a central medium through which societies around the world negotiate who they are, where they come from, and what shared futures for our world can be imagined,” says Professor Loy. “I therefore understand this award primarily as a mandate to continually re-explore the critical potential of literature through my research in times of reactionary political tendencies, and in particular to make it accessible and tangible for students and the broader public.”

Enlarge

Also honored was physician Dr. Kami Alexander Pekayvaz, who is setting new standards in the field of cardiovascular research. His work combines clinical practice with cutting-edge systems biology: Using multi-omics analyses, he has demonstrated how the immune system and the heart interact closely—for example, in the case of a heart attack. His research provides important insights into the development of atherosclerosis and thrombosis and could potentially open new avenues for personalized therapies as well as more precise prognoses of disease progression.

“The goal of this work is to describe immune mechanisms by studying human material and to further elucidate the actual relevance of these key findings in the disease model from a mechanistic perspective, in order to enable new diagnostic and therapeutic options in cardiovascular medicine,” Pekayvaz explains regarding his award-winning research.

The Heinz Maier-Leibnitz Prize has been awarded annually since 1977 to particularly talented researchers who have developed an independent scientific profile at an early stage. It is named after the physicist Heinz Maier-Leibnitz. The aim of the award is to support outstanding scientists in their future careers and to provide them with additional freedom for innovative research.

The award ceremony will take place on June 11 in Berlin.